• 5313 Citations
  • 21 Scopus h-Index
20082019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Article

18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma

Youland, R. S., Packard, A. T., Blanchard, M. J., Arnett, A. L., Wiseman, G. A., Kottschade, L. A., Dronca, R. S., Markovic, S. N., Olivier, K. R. & Park, S. S., Apr 1 2017, In : Advances in Radiation Oncology. 2, 2, p. 204-210 7 p.

Research output: Contribution to journalArticle

8 Scopus citations

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trial

Robert, C., Ribas, A., Wolchok, J. D., Hodi, F. S., Hamid, O., Kefford, R., Weber, J. S., Joshua, A. M., Hwu, W. J., Gangadhar, T. C., Patnaik, A., Dronca, R., Zarour, H., Joseph, R. W., Boasberg, P., Chmielowski, B., Mateus, C., Postow, M. A., Gergich, K., Elassaiss-Schaap, J. & 5 others, Li, X. N., Iannone, R., Ebbinghaus, S. W., Kang, S. P. & Daud, A., Sep 20 2014, In : The Lancet. 384, 9948, p. 1109-1117 9 p.

Research output: Contribution to journalArticle

1106 Scopus citations

Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma

Leon-Ferre, R. A., Kottschade, L. A., Block, M. S., Mc Williams, R. R., Dronca, R. S., Creagan, E. T., Allred, J. B., Lowe, V. & Markovic, S. N., Mar 14 2017, (Accepted/In press) In : Melanoma Research.

Research output: Contribution to journalArticle

7 Scopus citations

Association of pembrolizumab with tumor response and survival among patients with advanced melanoma

Ribas, A., Hamid, O., Daud, A., Hodi, F. S., Wolchok, J. D., Kefford, R., Joshua, A. M., Patnaik, A., Hwu, W. J., Weber, J. S., Gangadhar, T. C., Hersey, P., Dronca, R. S., Joseph, R. W., Zarour, H., Chmielowski, B., Lawrence, D. P., Algazi, A., Rizvi, N. A., Hoffner, B. & 8 others, Mateus, C., Gergich, K., Lindia, J. A., Giannotti, M., Li, X. N., Ebbinghaus, S., Kang, S. P. & Robert, C., Apr 19 2016, In : JAMA - Journal of the American Medical Association. 315, 15, p. 1600-1609 10 p.

Research output: Contribution to journalArticle

454 Scopus citations

A T cell memory problem?

Dronca, R. S., Jan 20 2016, In : Science Translational Medicine. 8, 322, 322ec10.

Research output: Contribution to journalArticle

Baseline tumor size is an independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab

Joseph, R. W., Elassaiss-Schaap, J., Kefford, R., Hwu, W. J., Wolchok, J. D., Joshua, A. M., Ribas, A., Hodi, F. S., Hamid, O., Robert, C., Daud, A., Dronca, R., Hersey, P., Weber, J. S., Patnaik, A., De Alwis, D. P., Perrone, A., Zhang, J., Kang, S. P., Ebbinghaus, S. & 2 others, Anderson, K. M. & Gangadhar, T. C., Oct 15 2018, In : Clinical Cancer Research. 24, 20, p. 4960-4967 8 p.

Research output: Contribution to journalArticle

51 Scopus citations

Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up

Zhang, B. Y., Thompson, R. H., Lohse, C. M., Dronca, R. S., Cheville, J. C., Kwon, E. D. & Leibovich, B. C., Jun 1 2013, In : BJU international. 111, 7, p. 1046-1053 8 p.

Research output: Contribution to journalArticle

28 Scopus citations

Cardiac metastasis in renal cell carcinoma without vena cava or atrial involvement: An unusual presentation of metastatic disease

Zhang, B., Malouf, J., Young, P., Kohli, M. & Dronca, R., Jul 15 2013, In : Rare Tumors. 5, 3, p. 103-105 3 p.

Research output: Contribution to journalArticle

11 Scopus citations

Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine

Vera, J., Paludo, J., Kottschade, L., Brandt, J., Yan, Y., Block, M. S., Mc Williams, R. R., Dronca, R. S., Loprinzi, C. L., Grothey, A. F. & Markovic, S. N., Jan 1 2019, In : Supportive Care in Cancer.

Research output: Contribution to journalArticle

2 Scopus citations

CD5+ B-cell lymphoproliferative disorders: Beyond chronic lymphocytic leukemia and mantle cell lymphoma

Jevremovic, D., Dronca, R. S., Morice, W. G., McPhail, E. D., Kurtin, P. J., Zent, C. S. & Hanson, C. A., Sep 1 2010, In : Leukemia Research. 34, 9, p. 1235-1238 4 p.

Research output: Contribution to journalArticle

23 Scopus citations

CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity

Dronca, R. S., Jevremovic, D., Hanson, C. A., Rabe, K. G., Shanafelt, T. D., Morice, W. G., Call, T. G., Kay, N. E., Collins, C. S., Schwager, S. M., Slager, S. L. & Zent, C. S., Sep 20 2010, In : Cytometry Part B - Clinical Cytometry. 78, SUPPL. 1, p. S35-S41

Research output: Contribution to journalArticle

21 Scopus citations

Contraction of T cell richness in lung cancer brain metastases

Mansfield, A., Ren, H., Sutor, S., Sarangi, V., Nair, A., Davila, J., Elsbernd, L. R., Udell, J. B., Dronca, R. S., Park, S. S., Markovic, S. N., Sun, Z. D., Halling, K. C., Nevala, W. K., Aubry, M. C., Dong, H. M. & Jen, J., Dec 1 2018, In : Scientific Reports. 8, 1, 2171.

Research output: Contribution to journalArticle

20 Scopus citations

CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy

Yan, Y., Cao, S., Liu, X., Harrington, S. M., Bindeman, W. E., Adjei, A. A., Jang, J. S., Jen, J., Li, Y., Chanana, P., Mansfield, A. S., Park, S. S., Markovic, S. N., Dronca, R. S. & Dong, H., Apr 19 2018, In : JCI insight. 3, 8

Research output: Contribution to journalArticle

Open Access
16 Scopus citations

Durable complete response after discontinuation of pembrolizumab in patients with metastatic melanoma

Robert, C., Ribas, A., Hamid, O., Daud, A., Wolchok, J. D., Joshua, A. M., Hwu, W. J., Weber, J. S., Gangadhar, T. C., Joseph, R. W., Dronca, R., Patnaik, A., Zarour, H., Kefford, R., Hersey, P., Zhang, J., Anderson, J., Diede, S. J., Ebbinghaus, S. & Hodi, F. S., Jun 10 2018, In : Journal of Clinical Oncology. 36, 17, p. 1668-1674 7 p.

Research output: Contribution to journalArticle

110 Scopus citations

Effect of the lymphocyte-to-monocyte ratio on the clinical outcome of chemotherapy administration in advanced melanoma patients

Leontovich, A. A., Dronca, R. S., Nevala, W. K., Thompson, M. A., Kottschade, L. A., Ivanov, L. V. & Markovic, S. N., 2017, In : Melanoma Research. 27, 1, p. 32-42 11 p.

Research output: Contribution to journalArticle

7 Scopus citations

Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States: An Expanded Access Program

Gangadhar, T. C., Hwu, W. J., Postow, M. A., Hamid, O., Daud, A., Dronca, R. S., Joseph, R. W., O'Day, S. J., Hodi, F. S., Pavlick, A. C., Kluger, H., Oxborough, R. P., Yang, A., Gazdoiu, M., Kush, D. A., Ebbinghaus, S. & Salama, A. K. S., 2017, In : Journal of Immunotherapy. 40, 9, p. 334-340 7 p.

Research output: Contribution to journalArticle

6 Scopus citations

Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients

Thompson, R. H., Boorjian, S. A., Kim, S. P., Cheville, J. C., Thapa, P., Tarrel, R., Dronca, R., Costello, B. & Frank, I., Jan 1 2014, In : BJU international. 113, 5 B, p. E17-E21

Research output: Contribution to journalArticle

33 Scopus citations

Evaluation of immune-related response criteria and RECIST v1.1 in patients with advanced melanoma treated with Pembrolizumab

Hodi, F. S., Hwu, W. J., Kefford, R., Weber, J. S., Daud, A., Hamid, O., Patnaik, A., Ribas, A., Robert, C., Gangadhar, T. C., Joshua, A. M., Hersey, P., Dronca, R. S., Joseph, R. W., Hille, D., Xue, D., Li, X. N., Kang, S. P., Ebbinghaus, S., Perrone, A. & 1 others, Wolchok, J. D., May 1 2016, In : Journal of Clinical Oncology. 34, 13, p. 1510-1517 8 p.

Research output: Contribution to journalArticle

353 Scopus citations

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

Hamid, O., Robert, C., Daud, A., Hodi, F. S., Hwu, W. J., Kefford, R., Wolchok, J. D., Hersey, P., Joseph, R., Weber, J. S., Dronca, R., Mitchell, T. C., Patnaik, A., Zarour, H. M., Joshua, A. M., Zhao, Q., Jensen, E., Ahsan, S., Ibrahim, N. & Ribas, A., Jan 1 2019, In : Annals of Oncology. 30, 4, p. 582-588 7 p., mdz011.

Research output: Contribution to journalArticle

Open Access
52 Scopus citations

Fluctuation of systemic immunity in melanoma and implications for timing of therapy

Leontovich, A. A., Dronca, R. S., Suman, V. J., Ashdown, M. L., Nevala, W. K., Thompson, M. A., Robinson, A., Kottschade, L. A., Kaur, J. S., McWilliams, R. R., Ivanov, L. V., Croghan, G. A. & Markovic, S. N., Jan 1 2012, In : Frontiers in Bioscience - Elite. 4 E, 3, p. 958-975 18 p.

Research output: Contribution to journalArticle

11 Scopus citations

Immune checkpoint molecules soluble program death ligand 1 and galectin-9 are increased in pregnancy

Enninga, E. A. L., Harrington, S. M., Creedon, D. J., Ruano, R., Markovic, S. N., Dong, H. M. & Dronca, R. S., Jan 1 2017, (Accepted/In press) In : American Journal of Reproductive Immunology.

Research output: Contribution to journalArticle

18 Scopus citations

Immunomodulatory antibody therapy of Cancer: The closer, the better

Dronca, R. S. & Dong, H. M., Mar 1 2015, In : Clinical Cancer Research. 21, 5, p. 944-946 3 p.

Research output: Contribution to journalArticle

7 Scopus citations

Immunotherapy: Fast and furious: Why all CARs are not made equal

Dronca, R. S., May 27 2015, In : Science Translational Medicine. 7, 289, 289ec86.

Research output: Contribution to journalArticle

Increasing incidence of melanoma among middle-aged adults: An epidemiologic study in olmsted county, minnesota

Lowe, G. C., Saavedra, A., Reed, K. B., Velazquez, A. I., Dronca, R. S., Markovic, S. N., Lohse, C. M. & Brewer, J. D., Jan 2014, In : Mayo Clinic proceedings. 89, 1, p. 52-59 8 p.

Research output: Contribution to journalArticle

29 Scopus citations

It takes three to tango

Dronca, R. S., Sep 9 2015, In : Science Translational Medicine. 7, 304, 304ec153.

Research output: Contribution to journalArticle

Low hypoxia inducible factor-1α (HIF-1α) expression in testicular germ cell tumors — a major reason for enhanced chemosensitivity?

Shenoy, N., Dronca, R. S., Quevedo, F., Boorjian, S. A., Cheville, J., Costello, B., Kohli, M., Witzig, T. E. & Pagliaro, L., Aug 1 2017, In : Chinese Journal of Cancer Research. 29, 4, p. 374-378 5 p.

Research output: Contribution to journalArticle

2 Scopus citations

Melanoma brain metastases and vemurafenib: Need for further investigation

Rochet, N. M., Dronca, R. S., Kottschade, L. A., Chavan, R. N., Gorman, B., Gilbertson, J. R. & Markovic, S. N., Oct 2012, In : Mayo Clinic proceedings. 87, 10, p. 976-981 6 p.

Research output: Contribution to journalArticle

35 Scopus citations

NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab±everolimus for metastatic melanoma

Mc Williams, R. R., Allred, J. B., Slostad, J. A., Katipamula, R., Dronca, R. S., Rumilla, K. M., Erickson, L. A., Bryce, A. H., Joseph, R. W., Kottschade, L. A., King, D. M., Leitch, J. M. & Markovic, S. N., 2017, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

4 Scopus citations
40 Scopus citations

Not just a fecal matter

Dronca, R. S., Dec 2 2015, In : Science Translational Medicine. 7, 316, 8023.

Research output: Contribution to journalArticle

NUT midline carcinoma: An aggressive intrathoracic neoplasm

Parikh, S. A., French, C. A., Costello, B. A., Marks, R. S., Dronca, R. S., Nerby, C. L., Roden, A. C., Peddareddigari, V. G., Hilton, J., Shapiro, G. I. & Molina, J. R., Jan 1 2013, In : Journal of Thoracic Oncology. 8, 10, p. 1335-1338 4 p.

Research output: Contribution to journalArticle

19 Scopus citations

Personalized therapy for metastatic melanoma: Could timing be everything?

Dronca, R. S., Leontovich, A. A., Nevala, W. K. & Markovic, S. N., Nov 1 2012, In : Future Oncology. 8, 11, p. 1401-1406 6 p.

Research output: Contribution to journalArticle

5 Scopus citations

Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: A north central cancer treatment group study, N0675

Dronca, R. S., Allred, J. B., Perez, D. G., Nevala, W. K., Lieser, E. A. T., Thompson, M., Maples, W. J., Creagan, E. T., Pockaj, B. A., Kaur, J. S., Moore, T. D., Marchello, B. T. & Markovic, S. N., Aug 2014, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 37, 4, p. 369-376 8 p.

Research output: Contribution to journalArticle

21 Scopus citations

Programmed death-ligand 1 expression and response to the anti-programmed death 1 antibody pembrolizumab in melanoma

Daud, A. I., Wolchok, J. D., Robert, C., Hwu, W. J., Weber, J. S., Ribas, A., Hodi, F. S., Joshua, A. M., Kefford, R., Hersey, P., Joseph, R. W., Gangadhar, T. C., Dronca, R. S., Patnaik, A., Zarour, H., Roach, C., Toland, G., Lunceford, J. K., Li, X. N., Emancipator, K. & 4 others, Dolled-Filhart, M., Kang, S. P., Ebbinghaus, S. & Hamid, O., Dec 1 2016, In : Journal of Clinical Oncology. 34, 34, p. 4102-4109 8 p.

Research output: Contribution to journalArticle

221 Scopus citations

Prospective Immunophenotyping of CD8+ T Cells and Associated Clinical Outcomes of Patients With Oligometastatic Prostate Cancer Treated With Metastasis-Directed SBRT

Evans, J. D., Morris, L. K., Zhang, H., Cao, S., Liu, X., Mara, K. C., Stish, B. J., Davis, B. J., Mansfield, A., Dronca, R. S., Iott, M. J., Kwon, E. D., Foote, R. L., Olivier, K. R., Dong, H. M. & Park, S. S., Jan 1 2019, In : International Journal of Radiation Oncology Biology Physics. 103, 1, p. 229-240 12 p.

Research output: Contribution to journalArticle

1 Scopus citations

Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era

Youland, R. S., Blanchard, M. L., Dronca, R. S., Kottschade, L., Markovic, S. N., Olivier, K. R. & Park, S. S., Oct 1 2017, In : Clinical and Translational Radiation Oncology. 6, p. 25-30 6 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma

Hamid, O., Robert, C., Daud, A., Hodi, F. S., Hwu, W. J., Kefford, R., Wolchok, J. D., Hersey, P., Joseph, R. W., Weber, J. S., Dronca, R., Gangadhar, T. C., Patnaik, A., Zarour, H., Joshua, A. M., Gergich, K., Elassaiss-Schaap, J., Algazi, A., Mateus, C., Boasberg, P. & 6 others, Tumeh, P. C., Chmielowski, B., Ebbinghaus, S. W., Li, X. N., Kang, S. P. & Ribas, A., Jan 1 2013, In : New England Journal of Medicine. 369, 2, p. 134-144 11 p.

Research output: Contribution to journalArticle

2203 Scopus citations

Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?

Duma, N., Abdel-Ghani, A., Yadav, S., Hoversten, K. P., Reed, C. T., Sitek, A. N., Enninga, E. A. L., Paludo, J., Aguilera, J. V., Leventakos, K., Lou, Y., Kottschade, L. A., Dong, H. M., Mansfield, A., Manochakian, R., Adjei, A. & Dronca, R. S., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalArticle

6 Scopus citations

Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011

Enninga, E. A. L., Moser, J. C., Weaver, A. L., Markovic, S. N., Brewer, J. D., Leontovich, A. A., Hieken, T. J., Shuster, L., Kottschade, L. A., Olariu, A., Mansfield, A. & Dronca, R. S., 2017, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

19 Scopus citations
120 Scopus citations
26 Scopus citations

The use of pembrolizumab for the treatment of metastatic uveal melanoma

Kottschade, L. A., Mc Williams, R. R., Markovic, S. N., Block, M. S., Villasboas Bisneto, J. J. C. ., Pham, A. Q., Esplin, B. L. & Dronca, R. S., Feb 4 2016, (Accepted/In press) In : Melanoma Research.

Research output: Contribution to journalArticle

48 Scopus citations

To beam or not to beam

Dronca, R. S., Oct 21 2015, In : Science Translational Medicine. 7, 310, 310ec179.

Research output: Contribution to journalArticle

Turning BiKEs into TriKEs to fight cancer

Dronca, R. S., Mar 2 2016, In : Science Translational Medicine. 8, 328, 328ec35.

Research output: Contribution to journalArticle

When instability is a good thing

Dronca, R. S., Jun 17 2015, In : Science Translational Medicine. 7, 292, 292ec100.

Research output: Contribution to journalArticle

Whole blood mRNA expression-based prognosis of metastatic renal cell carcinoma

Giridhar, K. V., Sosa, C. P., Hillman, D. W., Sanhueza, C., Dalpiaz, C. L., Costello, B. A., Quevedo, F. J., Pitot, H. C., Dronca, R. S., Ertz, D., Cheville, J. C., Donkena, K. V. & Kohli, M., Nov 3 2017, In : International journal of molecular sciences. 18, 11, 2326.

Research output: Contribution to journalArticle

6 Scopus citations

Why location is (still) everything

Dronca, R. S., Jul 29 2015, In : Science Translational Medicine. 7, 298, 298ec128.

Research output: Contribution to journalArticle

Chapter

Genitourinary malignancies

Dronca, R. & Kumar, A. B., Jan 5 2018, The Basics of Cancer Immunotherapy. Springer International Publishing, p. 79-94 16 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Nausea and vomiting

Dronca, R. S. & Loprinzi, C., Dec 1 2012, Management of Cancer in the Older Patient. Elsevier Inc., p. 171-181 11 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Comment/debate

A gender factor in shaping T-cell immunity to melanoma

Dronca, R. S. & Dong, H., Jan 1 2015, In : Frontiers in Oncology. 5, FEB, 8.

Research output: Contribution to journalComment/debate

7 Scopus citations